Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PI3K-IN-33 is a highly selective PI3K inhibitor that acts on PI3K-α (IC50: 11.73 μM), PI3K-β (IC50: 6.09 μM) and PI3K-δ (IC50: 11.18 μM). PI3K-IN-33 is capable of blocking the cell cycle in G2/M phase and can induce apoptosis and can be for the study of leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | PI3K-IN-33 is a highly selective PI3K inhibitor that acts on PI3K-α (IC50: 11.73 μM), PI3K-β (IC50: 6.09 μM) and PI3K-δ (IC50: 11.18 μM). PI3K-IN-33 is capable of blocking the cell cycle in G2/M phase and can induce apoptosis and can be for the study of leukemia. |
Molecular Weight | 493.36 |
Formula | C23H21BrN6O2 |
CAS No. | 2458163-92-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PI3K-IN-33 2458163-92-1 inhibitor inhibit